2025 annual financial data
Valion Bio 2025 Operating cash flow margin
Direct answer
Operating cash flow margin was -99.48%.
Operating income was -768,000 USD and net income was -8,878,000 USD.
Operating cash flow was -380,000 USD.
Get free Valion Bio email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 382,000 USD
- Operating income
- -768,000 USD
- Net income
- -8,878,000 USD
- Operating cash flow
- -380,000 USD